Comments on: Catalent Biologics and Cerenis Therapeutics Announce Phase III Trial of CER-001 in Europe and North America

Comments on: Catalent Biologics and Cerenis Therapeutics Announce Phase III Trial of CER-001 in Europe and North America /contractors/contract-manufacturers/catalent-pharma/pressreleases/presscatalent-biologics-cerenis-therapeutics-phase-iii-trial-cer-001-europe-north-america/ The leading site for news and procurement in the pharmaceutical industry Wed, 27 Jan 2016 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.7.2